renzapride has been researched along with piboserod in 1 studies
| Studies (renzapride) | Trials (renzapride) | Recent Studies (post-2010) (renzapride) | Studies (piboserod) | Trials (piboserod) | Recent Studies (post-2010) (piboserod) |
|---|---|---|---|---|---|
| 70 | 12 | 2 | 119 | 5 | 53 |
| Protein | Taxonomy | renzapride (IC50) | piboserod (IC50) |
|---|---|---|---|
| 5-hydroxytryptamine receptor 4 | Homo sapiens (human) | 0.0006 |
| Timeframe | Studies, this research(%) | All Research% |
|---|---|---|
| pre-1990 | 0 (0.00) | 18.7374 |
| 1990's | 0 (0.00) | 18.2507 |
| 2000's | 1 (100.00) | 29.6817 |
| 2010's | 0 (0.00) | 24.3611 |
| 2020's | 0 (0.00) | 2.80 |
| Authors | Studies |
|---|---|
| Hickling, RI; Meyers, NL | 1 |
1 other study(ies) available for renzapride and piboserod
| Article | Year |
|---|---|
Pharmacology and metabolism of renzapride : a novel therapeutic agent for the potential treatment of irritable bowel syndrome.
Topics: Animals; Benzamides; Bridged Bicyclo Compounds, Heterocyclic; Cytochrome P-450 Enzyme Inhibitors; Guinea Pigs; Humans; In Vitro Techniques; Irritable Bowel Syndrome; Microsomes, Liver; Radioligand Assay; Rats; Rats, Wistar; Receptors, Serotonin; Serotonin 5-HT3 Receptor Agonists; Serotonin 5-HT4 Receptor Antagonists; Stereoisomerism | 2008 |